Article
Validation of three BRCA1/2 mutation-carrier probability models Myriad, BRCAPRO and BOADICEA in a population-based series of 183 German families.
Familial cancer - 1 Jun 2012
Schneegans S M, Rosenberger A, Engel U, Sander M, Emons G, Shoukier M
Abstract excerpt
Many studies have evaluated the performance of risk assessment models for BRCA1/2 mutation carrier probabilities in different populations, but to our knowledge very few studies have been conducted in the German population so far. In the recent study, we validated the performance of three risk calculation models by names BRCAPRO, Myriad and BOADICEA in 183 German families who had undergone molecular testing of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.